George Abercrombie joins Inspire's board
This article was originally published in Scrip
Inspire Pharmaceuticals (US) has elected George Abercrombie to its board of directors. Mr Abercrombie most recently served as president and CEO of Roche Inc and head of North American pharmaceutical operations from 2001 to December 2009. During this time, he led the North American pharmaceutical operations for the Roche Group in the US and Canada. From 1997 to 2001, Mr Abercrombie was senior vice-president of commercial operations at Glaxo Wellcome.
You may also be interested in...
Latest EU company news: Sanofi grows OTC portfolio in France and Italy with ColdZyme; Germany's WindStar Medical gets UK owners; and France's Ipsen continues to fell effects of COVID-19 on sales.
Combination of antibody therapy and Gilead's Veklury fails to show potential in patients with advanced disease.
The FDA’s generic drug program yearly performance report shows that generic drug approvals declined for the first time in five years in fiscal year 2020, and the agency also reported a lower number of ANDA submissions.